Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Cornebarrieu – page 27

1 551 clinical trials in Cornebarrieu, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Cornebarrieu at a glance
1 551
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 551 trials in Cornebarrieu

Open in trial search

Study of sotorasib with chemotherapy combination for adult patients with advanced pancreatic cancer who have KRAS p.

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Asociacion Grupo Tratamiento De Tumores Digestivos

Study on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dimethyl Fumarate
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Alagille syndrome+1

Recruiting

Study on Long-Term Safety and Effects of Maralixibat for Patients with Alagille Syndrome

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Maralixibat
  • Sponsor:Mirum Pharmaceuticals Inc.

Safety Study of Sonrotoclax and Zanubrutinib for Patients with Untreated Chronic Lymphocytic Leukemia

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sonrotoclax
  • Sponsor:BeOne Medicines AG

Thermal burn

Recruiting

Study of dexamethasone effectiveness in reducing complications and mortality in patients with severe burns

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Universitaire De Nantes

Study on Rituximab for Patients with Rheumatoid Arthritis: Comparing 200 mg and 1g Doses for Maintenance Treatment

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Potassium Chloride
  • Sponsor:Les Hopitaux Universitaires De Strasbourg

Neoplasm

Recruiting

Study of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:ALE.P02
  • Sponsor:Alentis Therapeutics AG

Breast cancer

Recruiting

Study of inavolisib, palbociclib and letrozole combination for patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Inavolisib
  • Sponsor:F. Hoffmann-La Roche AG

Breast cancer+3

Recruiting

Study of ETX-19477 for Patients with Advanced Solid Tumors After Standard Treatment

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:ETX-19477
  • Sponsor:858 Therapeutics Inc.

Study on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Anaemia+1

Recruiting

Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept
  • Sponsor:Takeda Development Center Americas Inc.

Study on Obinutuzumab for Patients with Relapsing Granulomatosis with Polyangiitis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Assistance Publique Hopitaux De Paris

Other cities in France

The busiest research cities in the country

All 376 cities in France

Clinical research in Cornebarrieu

What the registry says about research in the country

01 Lung Cancer Research

Studies focusing on innovative treatments for non-small cell lung cancer, particularly evaluating immunotherapy combinations and targeted therapies for elderly patients.

  • Immunotherapy optimization
  • Elderly patient care protocols
  • Treatment effectiveness evaluation

Notable research includes novel approaches combining atezolizumab with traditional chemotherapy protocols.

02 Breast Cancer Studies

Comprehensive research on hormone-sensitive breast cancer, investigating optimized treatment durations and comparing therapeutic approaches for metastatic cases.

  • Hormone therapy optimization
  • Metastatic treatment strategies
  • Personalized therapy approaches

Research focuses on improving outcomes for patients with ER+ HER2- breast cancer variants.

03 Gastrointestinal Oncology

Advanced studies in colon carcinoma and biliary tract cancers, exploring both surgical and chemotherapy innovations.

  • Adjuvant treatment protocols
  • Neoadjuvant therapy assessment
  • Elderly patient care strategies

Including groundbreaking research on circulating tumor DNA for treatment decision-making.

04 Neurological Conditions

Innovative research in migraine management, exploring emergency interventions using advanced oxygen therapy techniques.

  • Emergency treatment protocols
  • High-flow oxygen therapy
  • Acute pain management

Focusing on rapid relief strategies in emergency department settings.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.